# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-19T10:57:19.137636
**Route:** Direct Google API + PDF
**Tokens:** 17278 in / 686 out
**Response SHA256:** 72f1c7b809a5a1b8

---

I have reviewed the draft paper "Click to Prescribe: Do Electronic Prescribing Mandates Reduce Opioid Mortality?" for fatal errors. Below is my evaluation.

**ADVISOR VERDICT: PASS**

I found no fatal errors in Data-Design Alignment, Regression Sanity, Completeness, or Internal Consistency.

### Detailed Checklist Results:

**1. Data-Design Alignment**
*   **Treatment timing vs data coverage:** The data covers 2015–2023. While several states are listed with mandate years prior to 2015 (Minnesota 2011), the author explicitly notes on pages 10 and 17 that these cohorts are treated as "always-treated" and do not contribute to the estimation of the ATT or pre-trends, which is a correct handling of the data window. The latest treatment year (2023 for CO and MD) is within the data coverage.
*   **Post-treatment observations:** For the main wave (2020–2021), there are multiple post-treatment years (2021, 2022, 2023).
*   **Consistency:** Table 4 (Appendix) mandate years align with the visualizations in Figure 1 and the regression samples.

**2. Regression Sanity**
*   **Standard Errors:** SEs in Table 2 and Table 3 are within plausible ranges for death rates per 100k (ranging from 0.085 to 4.46). No SEs exceed the magnitude of coefficients by 100x.
*   **Coefficients:** Log coefficients (Panel D, Table 2) are -0.199, which is well within the sanity range (< 10). Level coefficients for total deaths are around -4.5, which is plausible given the outcome means reported in Table 1.
*   **Impossible values:** No negative $R^2$ or SEs were found. Results contain no "NA" or "Inf" artifacts.

**3. Completeness**
*   **Placeholders:** Scanned the document for "TBD", "PLACEHOLDER", and "XXX"; none were found.
*   **Missing elements:** Regression tables include $N$ (Observations), state counts, and standard errors. Figure 4 exists and is correctly labeled.
*   **Analyses:** All methods mentioned (Sun-Abraham, TWFE, Log specs) have corresponding results reported in Table 2 or Table 3.

**4. Internal Consistency**
*   **Number matching:** The abstract cites a log ATT of -0.199 ($p=0.02$), which matches Table 2, Panel D and Table 3. The level estimate of 0.711 ($p=0.248$) matches Panel A, Column 1.
*   **Timing:** The sample period (2015-2023) is consistent across all tables and the text.
*   **Specifications:** Column headers in Table 2 accurately reflect the drug classes described in the Data section (T40.2, T40.4).

**ADVISOR VERDICT: PASS**